Hasnain Shah, MD,CM, MBA, FINR, FICA
Dr. Hasnain Haider-Shah, MD, CM, MBA,
FINR. FICA.DABR
Neurointerventional Surgeon | Interventional Radiologist I
Interventional Oncologist | Regenerative & Precision Longevity
Medicine Executive
Dr. Syed Hasnain Haider-Shah is a board-certified physician executive, Neurointerventional
Surgeon, Interventional Radiologist, and pioneer in regenerative and precision medicine with more than two decades of international clinical, academic, and healthcare leadership experience across North America, the Middle East, Europe, Asia and emerging healthcare markets.
He has served in senior clinical, advisory, and executive leadership positions spanning neurointerventional surgery, interventional oncology, precision diagnostics, regenerative medicine, longevity medicine, and healthcare innovation. Dr. Haider-Shah has advised hospitals, sovereign healthcare initiatives, private equity-backed healthcare ventures, and multinational medical AI technology projects focused on Healthcare Management Consulting, advancing patient-centered, technology-enabled models of care.
Dr. Haider-Shah is recognized for his work in advanced neuro-restoration and full body restoration , intra-arterial regenerative therapies, precision longevity programs, and the integration of artificial intelligence, advanced diagnostics, and regenerative biologics into modern healthcare systems.
His clinical and strategic work has included the development of multidisciplinary restoration programs addressing neurological, oncological, musculoskeletal, and age-related conditions.
As founding director of the Brockwell Investments and Healthcare Management Consulting he has offered bespoke facilities. The majority of his contracts have primarily been with Governmental , Private Equity, Venture Capital Investment Funds, Semi-Governmental Private and Public Healthcare Institutions. Expertise as a turn-around specialist for hospitals and clinics, and leading both brownfield and Greenfield projects.
As Co-Founder and Executive Leader of AEON Clinic Dubai, he helped establish and develop one of the region's recognized precision longevity and regenerative medicine platforms, contributing to strategic growth, clinical program development and protocol development , physician recruitment, answers staff recruitment, regenerative medicine integration, and the expansion of high-end longevity and performance medicine services for regional and international VVIP and general clientele.
Throughout his career, Dr. Haider-Shah has held consulting and leadership roles with major healthcare institutions and has participated in the development of advanced clinical programs in Regenerative Medicine, Neurointerventional Surgery, Interventional Oncology, precision health, and executive wellness.
He has also contributed to physician education, international training initiatives and the advancement of translational Regenerative Medicine programs across multinational platforms.
In addition to his clinical and executive activities, Dr. Haider-Shah serves as an educator, speaker, and advisor to healthcare organizations, medical technology companies, and emerging healthcare ventures. His current focus includes the development of integrated platforms combining Regenerative Medicine, Precision diagnostics, artificial intelligence, neuro-restoration, post oncology treatment restoration, and healthy Iongevity into scalable healthcare delivery models capable of serving both institutional and VVIP populations globally.
Selected Leadership Roles
• Co-Founder & Executive Leader, AEON Clinic Dubai
• Founder & Managing Director, Brockwell investments and Management Consulting and Brockwell Healthcare International LLC.
• Neurointerventional Surgeon for pediatrics and adults.
Interventional Oncologist and Interventional Radiologist for pediatrics and adults.
• Regenerative & Precision Longevity Medicine Executive
• Healthcare Innovation, Al, and Medical Technology Advisor
• International Speaker and Physician Educator
Financial relationships
-
Type of financial relationship:There are no financial relationships to disclose.Date added:09/02/2026Date updated:09/02/2026

Facebook
X
LinkedIn
Forward